Reflujo gastroesofágico

Bretagne, 2006, Comparative study of characteristics and disease management between subjects with frequent and occasional gastro-oesophageal reflux symptoms, Aliment Pharmacol Ther, 23, 607, 10.1111/j.1365-2036.2006.02811.x Bruley des Varannes, 2013, Gastroesophageal reflux disease: impact on work productivity and daily-life activities of daytime workers. A French cross-sectional study, Dig Liver Dis, 45, 200, 10.1016/j.dld.2012.11.005 Kahrilas, 2008, Gastroesophageal reflux disease, N Engl J Med, 359, 1700, 10.1056/NEJMcp0804684 Gordon, 2004, The role of the hiatus hernia in gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 20, 719, 10.1111/j.1365-2036.2004.02149.x van Herwaarden, 2004, The role of hiatus hernia in gastro-oesophageal reflux disease, Eur J Gastroenterol Hepatol, 16, 831, 10.1097/00042737-200409000-00003 Savarino, 2013, Dysmotility and reflux disease, Curr Opin Otolaryngol Head Neck Surg, 21, 548 Boeckxstaens, 2010, Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket, Best Pract Res Clin Gastroenterol, 24, 821, 10.1016/j.bpg.2010.08.011 Beaumont, 2010, The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD, Gut, 59, 441, 10.1136/gut.2009.178061 Galmiche, 2008, Review article: respiratory manifestations of gastro-oesophageal reflux disease, Aliment Pharmacol Ther, 27, 449, 10.1111/j.1365-2036.2008.03611.x Galmiche, 1998, Treatment of gastro-oesophageal reflux disease in adults. Clinical review, Br Med J, 316, 1720, 10.1136/bmj.316.7146.1720 Agence française de sécurité sanitaire des produits de santé, 2007 Haute Autorité de santé, 2009 Sachs, 2006, The clinical pharmacology of proton pump inhibitors, Aliment Pharmacol Ther, 23, 2, 10.1111/j.1365-2036.2006.02943.x Van Soest, 2006, Persistence and adherence to proton pump inhibitors in daily clinical practice, Aliment Pharmacol Ther, 24, 377, 10.1111/j.1365-2036.2006.02982.x Zerbib, 2006, Esophageal pH-impedance monitoring and symptom analysis in GERD: a study in patients off and on therapy, Am J Gastroenterol, 101, 1956, 10.1111/j.1572-0241.2006.00711.x Rohof, 2012, Effect of azitromycin on acid reflux, hiatus hernia and proximal acid pocket in the postprandial period, Gut, 61, 1670, 10.1136/gutjnl-2011-300926 Ciccaglione, 2003, Effect of acute and chronic administration of the GABAb agonist baclofen on 24-hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease, Gut, 52, 464, 10.1136/gut.52.4.464 Sifrim, 2012, Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors, Gut, 61, 1340, 10.1136/gutjnl-2011-301897 Vaezi, 1994, Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system, Am J Physiol, 267, G1050 Sifrim, 2004, Acid, weakly acidic and non-acid gastro-oesophageal reflux: differences, prevalence, and clinical relevance, Eur J Gastroenterol Hepatol, 16, 823, 10.1097/00042737-200409000-00002 Marshall, 1997, The relationship between acid and bile reflux in symptoms in gastrooesophageal reflux disease, Gut, 40, 182, 10.1136/gut.40.2.182 Zerbib, 2012, Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease, Gut, 61, 501, 10.1136/gutjnl-2011-300798 Mainie, 2006, Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication, Br J Surg, 93, 1483, 10.1002/bjs.5493 Broeders, 2011, Effects of anti-reflux surgery on weakly acidic reflux and belching, Gut, 60, 435, 10.1136/gut.2010.224824 Galmiche, 2011, Laparoscopic antireflux surgery versus esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial, JAMA, 305, 1969, 10.1001/jama.2011.626 Rodriguez, 2013, Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: final results of open-label prospective trial, Surg Endosc, 27, 1083, 10.1007/s00464-012-2561-4 Ganz, 2013, Esophageal sphincter device for gastroesophageal reflux disease, N Engl J Med, 368, 719, 10.1056/NEJMoa1205544 Johnson, 2004, Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease, Gastroenterology, 126, 660, 10.1053/j.gastro.2003.12.001 Siersema, 2009, Dilatation of refractory benign strictures, Gastrointest Endosc, 70, 1000, 10.1016/j.gie.2009.07.004 Kochman, 2005, The refractory and the recurrent esophageal stricture: a definition, Gastrointest Endosc, 62, 474, 10.1016/j.gie.2005.04.050 Richter, 2005, The management of heartburn in pregnancy, Aliment Pharmacol Ther, 22, 749, 10.1111/j.1365-2036.2005.02654.x Malfertheiner, 2012, A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy, BMC Gastroenterol, 12, 131, 10.1186/1471-230X-12-131 Richter, 2003, Gastroesophageal reflux disease during pregnancy, Gastroenterol Clin North Am, 32, 235, 10.1016/S0889-8553(02)00065-1 Rey, 2007, Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study, Am J Gastroenterol, 102, 2395, 10.1111/j.1572-0241.2007.01452.x Gerson, 2012, Treatment of gastroesophageal reflux disease during pregnancy, Gastroenterol Hepatol, 8, 763 Mahadevan, 2006, American Gastroenterological Association institute medical position statement on the use of gastrointestinal medications in pregnancy, Gastroenterology, 131, 278, 10.1053/j.gastro.2006.04.048 Garbis, 2005, Pregnancy outcome after exposure to ranitidine and others H2-blockers. A collaborative study of the European Network of Teratology Information Services, Reprod Toxicol, 19, 453, 10.1016/j.reprotox.2004.09.002 Majithia, 2012, Are proton pump inhibitors safe during pregnancy and lactation? Evidence to date, Drugs, 72, 171, 10.2165/11597290-000000000-00000 Zhu, 1993, Features of symptomatic gastro-esophageal reflux in elderly patients, Scand J Gastroenterol, 28, 235, 10.3109/00365529309096078 Collen, 1994, Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease, Am J Gastroenterol, 89, 712 Hurwitz, 1997, Gastric acidity in older adults, JAMA, 278, 659, 10.1001/jama.1997.03550080069041 Pilotto, 2006, Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients, J Am Geriatr Soc, 54, 1537, 10.1111/j.1532-5415.2006.00899.x Angiolillo, 2011, Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in the healthy subjects: randomized, placebo-controlled, crossover comparison studies, Clin Pharmacol Ther, 89, 65, 10.1038/clpt.2010.219 Andersson, 2014, Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers, Am J Cardiovasc Drugs, 14, 217, 10.1007/s40256-014-0073-4 El-Serag, 2005, Obesity is an independent risk factor for GERD symptoms and erosive esophagitis, Am J Gastroenterol, 100, 1243, 10.1111/j.1572-0241.2005.41703.x Murray, 2003, Relationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter project, Int J Epidemiol, 32, 645, 10.1093/ije/dyg108 Nocon, 2006, Lifestyle factors and symptoms of gastro-oesophageal reflux-a population based study, Aliment Pharmacol Ther, 23, 169, 10.1111/j.1365-2036.2006.02727.x Corley, 2007, Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms, Gut, 56, 756, 10.1136/gut.2006.109413 El-Serag, 2005, Abdominal obesity and the risk of Barrett's esophagus, Am J Gastroenterol, 100, 2151, 10.1111/j.1572-0241.2005.00251.x Nocom, 2007, Association of body mass index with heartburn, regurgitation and oesophagitis: results of the Progression of Gastroesophageal Reflux Disease study, J Gastroenterol Hepatol, 22, 1728, 10.1111/j.1440-1746.2006.04549.x Corley, 2006, Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis, Am J Gastroenterol, 108, 2619, 10.1111/j.1572-0241.2006.00849.x Zalar, 2013, Lack of correlation between morbid obesity and severe gastroesophageal reflux disease in candidates for bariatric surgery: results of a large prospective study, Obes Surg, 23, 1939, 10.1007/s11695-013-1064-2 Nelsen, 2012, Distribution of body fat and its influence on esophageal inflammation and dysplasia in patients with Barrett's esophagus, Clin Gastroenterol Hepatol, 10, 728, 10.1016/j.cgh.2012.03.007 El-Serag, 2014, Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barett's oesophagus: a case control study, Gut, 63, 220, 10.1136/gutjnl-2012-304189 Morgenthal, 2007, Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes, Surg Endosc, 21, 1978, 10.1007/s00464-007-9490-7 El-Hadi, 2014, The effect of bariatric surgery on gastroesophageal reflux disease, Can J Surg, 57, 139, 10.1503/cjs.030612 Malfertheiner, 2012, Management of Helicobacter pylori infection—the Maastricht IV/Florence Consensus Report, Gut, 61, 646, 10.1136/gutjnl-2012-302084 Shahabi, 2008, Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism, Immunol Cell Biol, 86, 175, 10.1038/sj.icb.7100119 Rubenstein, 2014, Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms, Clin Gastroenterol Hepatol, 12, 239, 10.1016/j.cgh.2013.08.029